226 related articles for article (PubMed ID: 26932701)
1. Hyperuricemia as a Risk Factors of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome: a Retrospective Cohort Study.
Karim B; Nasution SA; Wijaya IP; Harimurti K
Acta Med Indones; 2015 Oct; 47(4):320-5. PubMed ID: 26932701
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia as a prognostic factor after acute coronary syndrome.
Lopez-Pineda A; Cordero A; Carratala-Munuera C; Orozco-Beltran D; Quesada JA; Bertomeu-Gonzalez V; Gil-Guillen VF; Bertomeu-Martinez V
Atherosclerosis; 2018 Feb; 269():229-235. PubMed ID: 29407598
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fragmented QRS (fQRS) As A Predictor of Major Adverse Cardiac Event within 30 days in Acute Coronary Syndrome Patients: A Retrospective Cohort Study.
Dinakrisma AA; Wijaya IP; Nasution SA; Dewiasty E
Acta Med Indones; 2019 Jan; 51(1):3-9. PubMed ID: 31073100
[TBL] [Abstract][Full Text] [Related]
4. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
Whellan DJ; Tricoci P; Chen E; Huang Z; Leibowitz D; Vranckx P; Marhefka GD; Held C; Nicolau JC; Storey RF; Ruzyllo W; Huber K; Sinnaeve P; Weiss AT; Dery JP; Moliterno DJ; Van de Werf F; Aylward PE; White HD; Armstrong PW; Wallentin L; Strony J; Harrington RA; Mahaffey KW
J Am Coll Cardiol; 2014 Mar; 63(11):1048-57. PubMed ID: 24211500
[TBL] [Abstract][Full Text] [Related]
5. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
Kojima S; Sakamoto T; Ishihara M; Kimura K; Miyazaki S; Yamagishi M; Tei C; Hiraoka H; Sonoda M; Tsuchihashi K; Shimoyama N; Honda T; Ogata Y; Matsui K; Ogawa H;
Am J Cardiol; 2005 Aug; 96(4):489-95. PubMed ID: 16098298
[TBL] [Abstract][Full Text] [Related]
6. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Tscharre M; Herman R; Rohla M; Hauser C; Farhan S; Freynhofer MK; Huber K; Weiss TW
Atherosclerosis; 2018 Mar; 270():173-179. PubMed ID: 29432935
[TBL] [Abstract][Full Text] [Related]
7. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Brodov Y; Behar S; Boyko V; Chouraqui P
Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
Palmerini T; Genereux P; Caixeta A; Cristea E; Lansky A; Mehran R; Dangas G; Lazar D; Sanchez R; Fahy M; Xu K; Stone GW
J Am Coll Cardiol; 2011 Jun; 57(24):2389-97. PubMed ID: 21658558
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
10. Impact of Acute Coronary Syndrome Complicated by Ventricular Fibrillation on Long-term Incidence of Sudden Cardiac Death.
Álvarez-Álvarez B; Bouzas-Cruz N; Abu-Assi E; Raposeiras-Roubin S; López-López A; González Cambeiro MC; Peña-Gil C; García-Acuña JM; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):878-84. PubMed ID: 25800166
[TBL] [Abstract][Full Text] [Related]
11. Early and long-term outcomes after percutaneous coronary intervention of unprotected left main coronary disease with drug-eluting stents in patients with non-ST-elevation acute coronary syndrome.
Zhao C; Wang X; Wu X; Cui L
Can J Cardiol; 2011; 27(6):743-8. PubMed ID: 21875777
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, management and outcomes of patients with acute coronary syndrome and prior coronary artery bypass surgery: findings from the second Gulf Registry of Acute Coronary Events.
Al-Aqeedi R; Sulaiman K; Al Suwaidi J; Alhabib K; El-Menyar A; Panduranga P; Alshiekh-Ali A; Al Saif S
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):611-8. PubMed ID: 21920933
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
[TBL] [Abstract][Full Text] [Related]
14. Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia.
Okazaki H; Shirakabe A; Kobayashi N; Hata N; Shinada T; Matsushita M; Yamamoto Y; Shibata Y; Shibuya J; Shiomura R; Nishigoori S; Asai K; Shimizu W
Heart Vessels; 2017 Apr; 32(4):436-445. PubMed ID: 27672076
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; Beltrami M; Giordano N; Nuti R; McCullough PA
Am J Cardiol; 2016 May; 117(10):1616-1621. PubMed ID: 27040576
[TBL] [Abstract][Full Text] [Related]
16. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
[TBL] [Abstract][Full Text] [Related]
17. Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction.
Ranjith N; Myeni NN; Sartorius B; Mayise C
Metab Syndr Relat Disord; 2017 Feb; 15(1):18-25. PubMed ID: 27937806
[TBL] [Abstract][Full Text] [Related]
18. Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients - a single center prospective randomized controlled study in a Chinese population.
Du L; Dong P; Jia J; Li Z; Lai L; Yang X; Wang S; Yang X; Li Z; Shang X; Fan X
Eur J Prev Cardiol; 2016 Jul; 23(10):1077-85. PubMed ID: 26416996
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study.
Puricel S; Adorjan P; Oberhänsli M; Stauffer JC; Moschovitis A; Vogel R; Goy JJ; Müller O; Eeckhout E; Togni M; Wenaweser P; Meier B; Windecker S; Cook S
EuroIntervention; 2011 Oct; 7(6):697-704. PubMed ID: 21986328
[TBL] [Abstract][Full Text] [Related]
20. Impact of Accumulated Serum Uric Acid on Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes in Patients with Acute Coronary Syndrome.
Kobayashi N; Asai K; Tsurumi M; Shibata Y; Okazaki H; Shirakabe A; Goda H; Uchiyama S; Tani K; Takano M; Shimizu W
Cardiology; 2018; 141(4):190-198. PubMed ID: 30759435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
